Isoflavone soy protein supplementation and atherosclerosis progression in healthy postmenopausal women: a randomized controlled trial. - Wikidata - awgldk - TriplyDB

Isoflavone soy protein supplementation and atherosclerosis progression in healthy postmenopausal women: a randomized controlled trial.

Isoflavone soy protein supplementation and atherosclerosis progression in healthy postmenopausal women: a randomized controlled trial.

http://www.wikidata.org/entity/Q35449373

about

The impact of equol-producing status in modifying the effect of soya isoflavones on risk factors for CHD: a systematic review of randomised controlled trials Anti-Inflammatory Diet for Atherosclerosis and Coronary Artery Disease: Antioxidant Foods Soy and Health Update: Evaluation of the Clinical and Epidemiologic Literature Methods and baseline cardiovascular data from the Early versus Late Intervention Trial with Estradiol testing the menopausal hormone timing hypothesis Effect of prior oophorectomy on changes in bone mineral density and carotid artery intima-media thickness in postmenopausal women.Associations between urine excretion of isoflavonoids and cognition in postmenopausal women in the Women's Isoflavone Soy Health clinical trial.Therapeutic effects of isoflavones on impaired salivary secretion Beneficial effects of soy supplementation on postmenopausal atherosclerosis are dependent on pretreatment stage of plaque progression Abnormal blood rheology and chronic low grade inflammation: possible risk factors for accelerated atherosclerosis and coronary artery disease in Lewis negative subjects.Absorption, distribution, metabolism, and excretion of isoflavonoids after soy intake.Soy proteins and isoflavones reduce interleukin-6 but not serum lipids in older women: a randomized controlled trial A Systematic Review of the Efficacy of Bioactive Compounds in Cardiovascular Disease: Phenolic Compounds.Long-term soy isoflavone supplementation and cognition in women: a randomized, controlled trial.Self-reported menopausal symptoms, coronary artery calcification, and carotid intima-media thickness in recently menopausal women screened for the Kronos early estrogen prevention study (KEEPS)The timing hypothesis for coronary heart disease prevention with hormone therapy: past, present and future in perspective Anti-Atherosclerotic Effects of a Phytoestrogen-Rich Herbal Preparation in Postmenopausal Women.Do differences in risk factors explain the lower rates of coronary heart disease in Japanese versus U.S. women?Effect of isoflavone soy protein supplementation on endometrial thickness, hyperplasia, and endometrial cancer risk in postmenopausal women: a randomized controlled trial.Components of air pollution and cognitive function in middle-aged and older adults in Los Angeles.Effects of equol on gene expression in female cynomolgus monkey iliac arteries.Exploring the benefits and challenges of establishing a DRI-like process for bioactives Can breast cancer patients use soyafoods to help reduce risk of CHD?Bioavailability, bioactivity and impact on health of dietary flavonoids and related compounds: an update.Significant inverse association of equol-producer status with coronary artery calcification but not dietary isoflavones in healthy Japanese men.Relationship of equol production between children aged 5-7 years and their mothers.Effects of Vegetables on Cardiovascular Diseases and Related Mechanisms.Urinary phytoestrogens and cancer, cardiovascular, and all-cause mortality in the continuous National Health and Nutrition Examination Survey.Long-term kinetics of daidzein and its main metabolites in human equol-producers after soymilk intake: identification of equol-conjugates by UPLC-orbitrap-MS and influence of the number of transforming bacteria on plasma kinetics.Polyphenols and Oxidative Stress in Atherosclerosis-Related Ischemic Heart Disease and Stroke.Red clover isoflavones enriched with formononetin lower serum LDL cholesterol-a randomized, double-blind, placebo-controlled study.Whole soy, but not purified daidzein, had a favorable effect on improvement of cardiovascular risks: a 6-month randomized, double-blind, and placebo-controlled trial in equol-producing postmenopausal women.Natural approaches in metabolic syndrome management.

P2860

Q26740096-D2807D3B-1564-41D4-861D-E223CB06A785 Q26798027-8D628C69-7B44-494D-910C-316501BFB930 Q28071946-35D9DC11-067B-484D-BFE5-063ED7B88AE5 Q30868399-A312D7FD-944C-48F7-9270-7201B4F98364 Q34430166-E418D87E-9487-4CFB-BB05-72C3A5BB28D3 Q34482804-1AE9BBEF-CFE7-426F-9F35-B688EAEE8851 Q34489963-2AC5D07E-DDA9-4C54-A73F-7814904F763C Q35024110-15316308-3E7B-4894-B09F-6A490A8B2432 Q35091297-05C2359E-4556-4EFE-B18D-67A6D1644C6B Q35629651-E230C590-D76B-4E21-8A21-BDD74AC8FCDE Q35675357-BB5641CB-EFD2-427C-B32F-C83ECBF386B1 Q35894953-7D547212-C9C7-447B-BD66-5C7A2A3061F5 Q36014731-F9151393-6303-4FAE-A393-9DFA221A64F7 Q36736281-60643E37-BBC5-4882-B7C6-F0C61241B2F3 Q36781520-5E3516E2-8EF0-405C-8344-35A1AE65701D Q37210143-ED778A34-14B8-4AC0-91F5-2D73F1BB2CE0 Q37286959-27294731-C393-41D7-8C14-895EE730B7D3 Q37602011-36C086A9-337E-43A4-8A68-2B2179391428 Q37624634-1D7FE97D-26D8-45EF-ACB6-D1822468024C Q37678542-42BFF34F-F9B6-472A-966B-904DE6C723BC Q37710419-3665D5F8-BD5B-4411-8B13-BFC0442D12C5 Q38032972-AB038BB6-DF55-47AE-B6F9-20C8A1527143 Q38245598-B130D093-56FF-4DDE-9353-6554E7B4C521 Q40333462-D6816453-10F2-4BA9-A9CA-337FDCE06267 Q40721715-BC83FC76-4960-41E1-B8CF-A66109397D4A Q41584115-8DE071DF-77B5-4D52-9A88-BC6963B38F93 Q41759958-47D3E36B-FD0F-4C03-877D-C0EF1E80E832 Q47945703-E418DD0A-04D4-4B2F-A2EE-398D01E41696 Q48275729-8F85190F-FC6D-4BDF-8DDD-BF9A731852F8 Q50457468-D711D417-5EB8-47A3-990F-E2DA5A8915CF Q51330900-11C0294C-5E93-423B-8512-CF143414FACF Q51758644-C0BF22EE-73E8-4ED8-9153-8E195E3064ED

P2860

Isoflavone soy protein supplementation and atherosclerosis progression in healthy postmenopausal women: a randomized controlled trial.

http://www.wikidata.org/entity/Q35449373

description

2011 nî lūn-bûn

@nan

2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Isoflavone soy protein supplem ...... a randomized controlled trial.

@ast

Isoflavone soy protein supplem ...... a randomized controlled trial.

@en

type

label

Isoflavone soy protein supplem ...... a randomized controlled trial.

@ast

Isoflavone soy protein supplem ...... a randomized controlled trial.

@en

prefLabel

Isoflavone soy protein supplem ...... a randomized controlled trial.

@ast

Isoflavone soy protein supplem ...... a randomized controlled trial.

@en

P1433

Q35449373-111709C2-FE58-46CF-B002-F65CB41AE4B5

P1476

Q35449373-16C855ED-6E8F-4447-9335-0EC4835B22C2

P2093

Q35449373-04B03D80-661E-46B6-AFF4-4B56D7885183

Q35449373-0A4994D7-4A12-4707-97ED-F7CF03A86C5F

Q35449373-33C9B540-B2DA-4B8B-81F0-B66849289C74

Q35449373-57A9391E-54A0-4443-A72E-CFFC8A400263

Q35449373-5EEB7793-FC18-4530-AB3D-0A027C314929

Q35449373-6DE3E2FE-7364-4369-82C6-42B16D8B9791

Q35449373-7F612737-850A-4838-8F52-7AFA80F4A1D4

Q35449373-8497BFEB-F77E-4946-9D39-1815A8FC64A2

Q35449373-9F44DADF-4A49-42DE-810C-58D9520714AC

Q35449373-C60BCFB1-21C4-4A34-B20E-869DE07778D5

P2860

Q35449373-006B9AB3-A2C8-48BF-BFF3-0D71034F7A8D

Q35449373-014DCAD8-9C0D-4273-9E56-F2D0CBD48633

Q35449373-0ABAB915-E8D8-4AC9-B9D6-23BBE13CF5AA

Q35449373-0DA3086C-9466-4FF8-A811-E7AC2B24632A

Q35449373-188D2B89-29CD-42FA-9A1C-C63DF70535D8

Q35449373-1C3F3186-CE24-4E30-A7D1-FA3A2AB5C6A7

Q35449373-23EF3217-7988-4984-9489-C020A4F501F4

Q35449373-2931C088-02A4-4450-AA6D-230BE9264F9B

Q35449373-3100F7E6-7514-4E48-9A2B-92020CBE5A7D

Q35449373-36F7F9EE-F288-44BA-8A8C-CFAC0CEBFA63

P304

Q35449373-9B893150-717C-4EEF-9550-74F08DD63905

P31

Q35449373-02351238-E2E2-4115-B25B-C24C699280C1

P356

Q35449373-F2DE4B7F-8302-447F-BF8B-7640B50E3948

P407

Q35449373-E3EF2578-1B0C-4E34-8ED4-1E316FFA1ECB

P433

Q35449373-9986DEBD-8931-4029-96A6-2FF8A0439150

P478

Q35449373-7DCDDA83-D4B6-40BD-BF0E-2DADD6A1E678

P577

Q35449373-77187635-2EF6-40C2-922F-D17025E81C0E

P698

Q35449373-587DAF2A-B762-4DB1-97FD-16C05B3C7F63

P921

Q35449373-D8E0A595-984D-46A8-8834-F7B1D33E9EAC

P932

Q35449373-837202FB-D32B-45CB-8825-FDB2C4C7D152

P356

STROKEAHA.111.620831

P1433

P1476

Isoflavone soy protein supplem ...... a randomized controlled trial.

@en

P2093

Adrian A Franke

http://www.w3.org/2001/XMLSchema#string

Diana Petitti

http://www.w3.org/2001/XMLSchema#string

Donna Shoupe

http://www.w3.org/2001/XMLSchema#string

Howard N Hodis

http://www.w3.org/2001/XMLSchema#string

Juliana Hwang-Levine

http://www.w3.org/2001/XMLSchema#string

Lora Whitfield-Maxwell

http://www.w3.org/2001/XMLSchema#string

Mingzhu Yan

http://www.w3.org/2001/XMLSchema#string

Naoko Kono

http://www.w3.org/2001/XMLSchema#string

Robert H Selzer

http://www.w3.org/2001/XMLSchema#string

Stanley P Azen

http://www.w3.org/2001/XMLSchema#string

P2860

Interaction of phytoestrogens with estrogen receptors alpha and beta

Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta

Soy protein, isoflavones, and cardiovascular health: an American Heart Association Science Advisory for professionals from the Nutrition Committee

Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta

Unconventional medicine in the United States. Prevalence, costs, and patterns of use

Soy and alfalfa phytoestrogen extracts become potent low-density lipoprotein antioxidants in the presence of acerola cherry extract.

Soy, its components, and cancer prevention: a review of the in vitro, animal, and human data.

Inhibition of postmenopausal atherosclerosis progression: a comparison of the effects of conjugated equine estrogens and soy phytoestrogens.

Intake of dietary phytoestrogens is low in postmenopausal women in the United States: the Framingham study(1-4).

The clinical importance of the metabolite equol-a clue to the effectiveness of soy and its isoflavones.

P304

3168-3175

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/STROKEAHA.111.620831

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

42

http://www.w3.org/2001/XMLSchema#string

P577

2011-09-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21903957

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis

P932

3202054

http://www.w3.org/2001/XMLSchema#string